REVIEW PAPER
Ferritin – novel uses of a well-known marker in paediatrics
 
More details
Hide details
1
Department of Pediatric Oncology and Hematology, Medical University of Bialystok, Bialystok, Poland
 
 
Submission date: 2022-10-15
 
 
Final revision date: 2022-11-21
 
 
Acceptance date: 2022-11-25
 
 
Publication date: 2023-03-24
 
 
Corresponding author
Małgorzata Sawicka-Żukowska
Małgorzata Sawicka-Żukowska, Department of Pediatric Oncology and Hematology, Medical University of Bialystok, Bialystok, Poland
 
 
Pediatr Pol 2023;98(1):57-65
 
KEYWORDS
TOPICS
ABSTRACT
Serum ferritin is one of the most widely used laboratory tests and is associated with both iron deficiency and iron overload. Currently, more and more attention is paid to the involvement of ferritin in processes other than iron metabolism. Low serum ferritin is unanimously associated with iron deficiency, while elevated serum ferritin may be a consequence of various medical conditions such as iron overload, an inflammatory process, SARS-CoV-2, organ failure, cancer, and endocrine disorders, including metabolic syndrome. We present a review of the literature on the role of ferritin in a variety of less obvious disease states in children.
REFERENCES (86)
1.
Harrison PM, Arosio P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta 1996; 1275: 161-203.
 
2.
Alkhateeb AA, Connor JR. Nuclear ferritin: a new role for ferritin in cell biology. Biochim Biophys Acta 2010; 1800: 793-797.
 
3.
Beaton MD, Adams PC. Treatment of hyperferritinemia. Ann Hepatol 2012; 11: 294-300.
 
4.
Cullis JO, Fitzsimons EJ, Griffiths WJ, et al. Investigation and management of a raised serum ferritin. Br J Haematol 2018; 181: 331-340.
 
5.
Alkhateeb AA, Connor JR. The significance of ferritin in cancer: anti-oxidation, inflammation and tumorigenesis. Biochim Biophys Acta 2013; 1836: 245-254.
 
6.
Chiou B, Connor JR. Emerging and dynamic biomedical uses of ferritin. Pharmaceuticals (Basel) 2018; 11: 124.
 
7.
Łęcka M, Słomka A, Albrecht K, et al. Unbalance in iron metabolism in childhood leukemia converges with treatment intensity: biochemical and clinical analysis. Cancers (Basel) 2021; 13: 3029.
 
8.
Récher C. Clinical implications of inflammation in acute myeloid leukemia. Front Oncol 2021; 11: 623952.
 
9.
Mahroum N, Alghory A, Kiyak Z, et al. Ferritin – from iron, through inflammation and autoimmunity, to COVID-19. J Autoimmun 2022; 126: 102778.
 
10.
Garcia PC, Longhi F, Branco RG, et al. Ferritin levels in children with severe sepsis and septic shock. Acta Paediatr 2007; 96: 1829-1831.
 
11.
Kernan KF, Carcillo JA. Hyperferritinemia and inflammation. Int Immunol 2017; 29: 401-409.
 
12.
Tonial CT, Garcia PCR, Schweitzer LC, et al. Cardiac dysfunction and ferritin as early markers of severity in pediatric sepsis. J Pediatr (Rio J) 2017; 93: 301-307.
 
13.
Carcillo JA, Sward K, Halstead ES, et al. A systemic inflammation mortality risk assessment contingency table for severe sepsis. Pediatr Crit Care Med 2017; 18: 143-150.
 
14.
Simon DW, Halstead ES, Davila S, et al. DNA viremia is associated with hyperferritinemia in pediatric sepsis. J Pediatr 2019; 213: 82-87.e2.
 
15.
Mithal LB, Palac HL, Yogev R, et al. Cord blood acute phase reactants predict early onset neonatal sepsis in preterm infants. PLoS One 2017; 12: e0168677.
 
16.
Giannattasio A, D’Anna C, Muzzica S, et al. Is COVID-19 a hyperferritinemic syndrome in children? Clin Chem Lab Med 2021; 59: e409-e412.
 
17.
Whittaker E, Bamford A, Kenny J, et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA 2020; 324: 259-269.
 
18.
Zachariah P, Johnson CL, Halabi KC, et al. Epidemiology, clinical features, and disease severity in patients with coronavirus disease 2019 (COVID-19) in a children’s hospital in New York City, New York. JAMA Pediatr 2020; 174: e202430.
 
19.
Henry BM, de Oliveira MHS, Benoit S, et al. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med 2020; 58: 1021-1028.
 
20.
Pereira MFB, Litvinov N, Farhat SCL, et al. Severe clinical spectrum with high mortality in pediatric patients with COVID-19 and multisystem inflammatory syndrome. Clinics (Sao Paulo) 2020; 75: e2209.
 
21.
Lu W, Yang L, Li X, et al. Early immune responses and prognostic factors in children with COVID-19: a single-center retrospective analysis. BMC Pediatr 2021; 21: 181.
 
22.
Valverde I, Singh Y, Sanchez-de-Toledo J, et al. Acute cardiovascular manifestations in 286 children with multisystem inflammatory syndrome associated with COVID-19 infection in Europe. Circulation 2021; 143: 21-32.
 
23.
Papillard-Marechal S, Sznajder M, Hurtado-Nedelec M, et al. Iron metabolism in patients with anorexia nervosa: elevated serum hepcidin concentrations in the absence of inflammation. Am J Clin Nutr 2012; 95: 548-554.
 
24.
Boillot A, Ringuenet D, Kapila Y, et al. High serum ferritin levels are associated with a reduced periodontium in women with anorexia nervosa. Eat Weight Disord 2020; 25: 1763-1770.
 
25.
Pires SAP, Soares JC, Luz AMBD, et al. Outpatient analytic assessment of anorexia nervosa – the importance of venous blood gases. Rev Paul Pediatr 2020; 38: e2018358.
 
26.
Kennedy A, Kohn M, Lammi A, et al. Iron status and haematological changes in adolescent female inpatients with anorexia nervosa. J Paediatr Child Health 2004; 40: 430-432.
 
27.
Salinas M, López-Garrigós M, Flores E, et al. Automated requests for thyroid-stimulating hormone and ferretin tests in young primary care patients with anorexia as an intervention to improve detection of underlying conditions. Lab Med 2019; 50: 268-272.
 
28.
Pettersson C, Svedlund A, Wallengren O, et al. Dietary intake and nutritional status in adolescents and young adults with anorexia nervosa: a 3-year follow-up study. Clin Nutr 2021; 40: 5391-5398.
 
29.
Shim YS, Kang MJ, Oh YJ, et al. Association of serum ferritin with insulin resistance, abdominal obesity, and metabolic syndrome in Korean adolescent and adults: The Korean National Health and Nutrition Examination Survey, 2008 to 2011. Medicine (Baltimore) 2017; 96: e6179.
 
30.
Shattnawi KK, Alomari MA, Al-Sheyab N, et al. The relationship between plasma ferritin levels and body mass index among adolescents. Sci Rep 2018; 8: 15307.
 
31.
Kim YE, Kim DH, Roh YK, et al. Relationship between serum ferritin levels and dyslipidemia in Korean adolescents. PLoS One 2016; 11: e0153167.
 
32.
Zhang J, Cao J, Xu H, et al. Ferritin as a key risk factor for nonalcoholic fatty liver disease in children with obesity. J Clin Lab Anal 2021; 35: e23602.
 
33.
Lombardi R, Pisano G, Fargion S. Role of serum uric acid and ferritin in the development and progression of NAFLD. Int J Mol Sci 2016; 17: 548.
 
34.
Ryoo JH, Kim SY, Oh CM, et al. The incidental relationship between serum ferritin levels and hypertension. Int J Cardiol 2015; 183: 258-262.
 
35.
Alam F, Memon AS, Fatima SS. Increased body mass index may lead to hyperferritinemia irrespective of body iron stores. Pak J Med Sci 2015; 31: 1521-1526.
 
36.
Metwalley KA, Raafat DM, Tamer DM, et al. Ferritin levels in children and adolescents with type 1 diabetes mellitus: relationship with microvascular complications and glycemic control. Arch Endocrinol Metab 2021; 64: 720-725.
 
37.
Hämäläinen P, Saltevo J, Kautiainen H, et al. Serum ferritin levels and the development of metabolic syndrome and its components: a 6.5-year follow-up study. Diabetol Metab Syndr 2014; 6: 114.
 
38.
Suárez-Ortegón MF, Blanco E, McLachlan S, et al. Ferritin levels throughout childhood and metabolic syndrome in adolescent stage. Nutr Metab Cardiovasc Dis 2019; 29: 268-278.
 
39.
Yi KH, Hwang JS, Lim SW, et al. Ferritin level is associated with metabolic syndrome and elevated alanine aminotransferase in children and adolescents. J Pediatr Endocrinol Metab 2016; 29: 1337-1344.
 
40.
Ellidag HY, Eren E, Akdag M, et al. The relationship between serum ferritin levels and serum lipids and HDL function with respect to age and gender. Ukr Biochem J 2016; 88: 76-86.
 
41.
Ayça S, Duru NS, Elevli M. Effects of anaemia parameters on metabolic control in children with type-1 diabetes mellitus. Istanbul Med J 2020; 21: 397-400.
 
42.
Størdal K, McArdle HJ, Hayes H, et al. Prenatal iron exposure and childhood type 1 diabetes. Sci Rep 2018; 8: 9067.
 
43.
Kim SH, Song ES, Yoon S, et al. Serum ferritin as a diagnostic biomarker for Kawasaki disease. Ann Lab Med 2021; 41: 318-322.
 
44.
Mizuta M, Shimizu M, Inoue N, et al. Serum ferritin levels as a useful diagnostic marker for the distinction of systemic juvenile idiopathic arthritis and Kawasaki disease. Mod Rheumatol 2016; 26: 929-932.
 
45.
Roh DE, Kwon JE, Choi HJ, et al. Importance of serum ferritin level for early diagnosis and differentiation in patients with Kawasaki disease with macrophage activation syndrome. Children (Basel) 2021; 8: 269.
 
46.
Guo L, Xu Y, Qian X, et al. Sudden hypotension and increased serum interferon-γ and interleukin-10 predict early macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. J Pediatr 2021; 235: 203-211.e3.
 
47.
Fall N, Barnes M, Thornton S, et al. Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome. Arthritis Rheum 2007; 56: 3793-3804.
 
48.
Kong WX, Ma FY, Fu SL, et al. Biomarkers of intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease. World J Pediatr 2019; 15: 168-175.
 
49.
Yamamoto N, Sato K, Hoshina T, et al. Utility of ferritin as a predictor of the patients with Kawasaki disease refractory to intravenous immunoglobulin therapy. Mod Rheumatol 2015; 25: 898-902.
 
50.
Choi YJ, Jeon JH, Oh JW. Critical combination of initial markers for predicting refractory Mycoplasma pneumoniae pneumonia in children: a case control study. Respir Res 2019; 20: 193.
 
51.
Tamura A, Matsubara K, Tanaka T, et al. Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children. J Infect 2008; 57: 223-228.
 
52.
Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003; 4: 101-119.
 
53.
Klingelhoefer L, Bhattacharya K, Reichmann H. Restless legs syndrome. Clin Med (Lond) 2016; 16: 379-382.
 
54.
Halac G, Sezer GM, Saglam NO, et al. The relationship between Willis-Ekbom disease and serum ferritin levels among children in Northwestern Turkey. Neurosciences (Riyadh) 2015; 20: 336-340.
 
55.
Rosen GM, Morrissette S, Larson A, et al. Does Improvement of low serum ferritin improve symptoms of restless legs syndrome in a cohort of pediatric patients? J Clin Sleep Med 2019; 15: 1149-1154.
 
56.
Maheswaran M, Kushida CA. Restless legs syndrome in children. MedGenMed 2006; 8: 79.
 
57.
Simakajornboon N, Gozal D, Vlasic V, et al. Periodic limb movements in sleep and iron status in children. Sleep 2003; 26: 735-738.
 
58.
Mohan R, Unnikrishnan PN, George H, et al. Is ferritin estimation and optimisation important in cerebral palsy children undergoing single event multilevel surgery? J Orthop 2019; 16: 1-4.
 
59.
Tomoum HY, Badawy NB, Hassan NE, et al. Anthropometry and body composition analysis in children with cerebral palsy. Clin Nutr 2010; 29: 477-481.
 
60.
McCann S, Perapoch Amadó M, Moore SE. The role of iron in brain development: a systematic review. Nutrients 2020; 12: 2001.
 
61.
Oner O, Oner P, Bozkurt OH, et al. Effects of zinc and ferritin levels on parent and teacher reported symptom scores in attention deficit hyperactivity disorder. Child Psychiatry Hum Dev 2010; 41: 441-447.
 
62.
Mahmoud MM, El-Mazary AA, Maher RM, et al. Zinc, ferritin, magnesium and copper in a group of Egyptian children with attention deficit hyperactivity disorder. Ital J Pediatr 2011; 37: 60.
 
63.
Juneja M, Jain R, Singh V, et al. Iron deficiency in Indian children with attention deficit hyperactivity disorder. Indian Pediatr 2010; 47: 955-958.
 
64.
Öztürk Y, Topal Z, Demir N, et al. Iron and ferritin levels of children and adolescents with ADHD and ADHD-NOS. J Pediatr Res 2020; 7: 216-222.
 
65.
Abd El Naby SA, Naguib YM. Sociodemographic, electrophysiological, and biochemical profiles in children with attention deficit hyperactivity disorder and/or epilepsy. Behav Neurol 2018; 2018: 8932817.
 
66.
Chen MH, Su TP, Chen YS, et al. Association between psychiatric disorders and iron deficiency anemia among children and adolescents: a nationwide population-based study. BMC Psychiatry 2013; 13: 161.
 
67.
Bener A, Khattab AO, Bhugra D, et al. Iron and vitamin D levels among autism spectrum disorders children. Ann Afr Med 2017; 16: 186-191.
 
68.
Eapen V, Usherwood T. Tourette syndrome in children. Aust J Gen Pract 2021; 50: 120-125.
 
69.
Gorman DA, Zhu H, Anderson GM, et al. Ferritin levels and their association with regional brain volumes in Tourette’s syndrome. Am J Psychiatry 2006; 163: 1264-1272.
 
70.
Parkin PC, Koroshegyi C, Mamak E, et al. Association between serum ferritin and cognitive function in early childhood. J Pediatr 2020; 217: 189-191.
 
71.
Ahmed BW, Hanoudi BM, Ibrahim BA. Risk factors in children with febrile seizures and their iron status. J Pak Med Assoc 2019; 69: S22-S25.
 
72.
Zareifar S, Hosseinzadeh HR, Cohan N. Association between iron status and febrile seizures in children. Seizure 2012; 21: 603-605.
 
73.
Daoud AS, Batieha A, Abu-Ekteish F, et al. Iron status: a possible risk factor for the first febrile seizure. Epilepsia 2002; 43: 740-743.
 
74.
Köksal AO, Özdemir O, Büyükkaragöz B, et al. The association between plasma ferritin level and simple febrile seizures in children. J Pediatr Hematol Oncol 2016; 38: 512-516.
 
75.
Jang HN, Yoon HS, Lee EH. Prospective case control study of iron deficiency and the risk of febrile seizures in children in South Korea. BMC Pediatr 2019; 19: 309.
 
76.
Papageorgiou V, Vargiami E, Kontopoulos E, et al. Association between iron deficiency and febrile seizures. Eur J Paediatr Neurol 2015; 19: 591-596.
 
77.
Yu J, Yu L, Li Y, et al. Iron deficiency is a possible risk factor causing right heart failure in Tibetan children living in high altitude area. Medicine (Baltimore) 2020; 99: e21133.
 
78.
Grote Beverborg N, Klip IT, Meijers WC, et al. Definition of iron deficiency based on the gold standard of bone marrow iron staining in heart failure patients. Circ Heart Fail 2018; 11: e004519.
 
79.
Itiola AY, Animasahun BA, Njokanma OF. Serum iron status of children with cyanotic congenital heart disease in Lagos, Nigeria. Sultan Qaboos Univ Med J 2019; 19: e345-e351.
 
80.
Demir F, Kayali S, Gokcebay DG. Does iron deficiency affect the heart in children? J Pediatr Hematol Oncol 2022; 44: 84-88.
 
81.
El-Waseef MM, Taha S, Elgindi H. Left ventricular diastolic abnormalities and the impact of hepatitis C virus infection in multitransfused Egyptian children. Arch Med Sci 2010; 6: 96-99.
 
82.
Ratledge C. Iron, mycobacteria and tuberculosis. Tuberculosis (Edinb) 2004; 84: 110-130.
 
83.
Carvalho I, Goletti D, Manga S, et al. Managing latent tuberculosis infection and tuberculosis in children. Pulmonology 2018; 24: 106-114.
 
84.
Comella-Del-Barrio P, Abellana R, Villar-Hernández R, et al. A Model Based on the Combination of IFN-γ, IP-10, Ferritin and 25-Hydroxyvitamin D for Discriminating Latent From Active Tuberculosis in Children. Front Microbiol 2019; 10: 1855.
 
85.
Pérez-Porcuna TM, Ascaso C, Malheiro A, et al. Mycobacterium tuberculosis infection in young children: analyzing the performance of the diagnostic tests. PLoS One 2014; 9: e97992.
 
86.
Manyelo CM, Chegou NN, Seddon JA, et al. Serum and cerebrospinal fluid host proteins indicate stroke in children with tuberculous meningitis. PLoS One 2021; 16: e0250944.
 
Journals System - logo
Scroll to top